ArticleEBioMedicine2017

Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy.

Eszter Lázár-Molnár et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.